Intravascular Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Intravascular Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy [Phase 2]
A Phase 2 clinical trial investigates golcadomide in combination with rituximab as bridging therapy for relapsed or refractory aggressive B-…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating circulating tumor DNA (ctDNA) testing in people with diffuse large B-cell lymphoma and related high-grade …
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma [Phase 2]
Phase 2 trial update on zanubrutinib combined with CAR T-cell therapy for recurrent or refractory aggressive B-cell non-Hodgkin lymphomas an…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating zanubrutinib combined with R-CHOP for newly diagnosed intravascular large B-cell lymphoma is being conducted; curre…